Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal By Investing.com Stocks December 31, 2024 Investing.com — Sangamo Therapeutics Inc (NASDAQ:) announced on Monday that Pfizer (NYSE:) has ended their partnership to co-develop a gene…